Conférences  >  Médecine & Soins de Santé  >  Cancérologie

INDEX Conferences And Exhibitions

The Asia Pacific Breast Cancer Summit (APBCS) is the region’s leading platform advancing breast cancer care through collaboration, innovation, and real-world clinical practice — uniting the region to improve outcomes.

Tél.: [+97145203624];     Email.: jayesh.chhetri@index.ae

The European Association for Cancer Research (EACR)

This conference will focus on the basic mechanisms controlling cancer cell signalling circuits at the transcriptome, proteome and phosphoproteome levels, as well as emerging concepts in cancer cell signalling and cutting-edge, OMICS-based insights. Despite decades of research, our global understanding of how cancer cell signalling circuits are controlled, and how they determine cancer progression and therapy resistance, is still far from complete. Join us online on 10 and 11 February 2026 to hear the latest science in this area from a panel of global experts. If you work in this field, submit an abstract before 15 December 2025 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation. Register by 19 January 2026 to secure your place as a participant.

Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org

cancer research, oncology, cancer cell signalling, cell signalling networks, cell signalling control mechanisms, cancer progression, cancer therapy resistance, post-translational protein regulation, transcriptional gene regulation, transcriptomics, proteomics, phosphoproteomics, kinases and phosphatases, signalling rewiring, signal integration, RNA biology in cancer

Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe

Motto: zusammen - gezielt - zukunftsfähig

Gemeinsame Gespräche mit Beteiligten aus Medizin, Pflege, Politik und unter enger Einbindung der Betroffenenorganisationen über die Onkologie der Zukunft mit einem ganzheitlichen Blick auf eine patientenzentrierte Forschung und Versorgung. Eine hohe Priorität hat auch die konsequente Nachwuchsförderung. Auch geht es um Chancen und Grenzen der künstlichen Intelligenz, Fragen der Versorgungsgerechtigkeit und die Herausforderungen einer zunehmenden Vielfalt der Betroffenen.

Tél.: [030 3229329-18];     Email.: dkk@krebsgesellschaft.de

Onkologie der Zukunft, gezielter Einsatz von Ressourcen, Versorgungsgerechtigkeit und Vielfalt in der Krebsmedizin, Partizipation/Stimmen der Betroffenen, Cancer Survivor, Palliativmedizin, u.v.m.

Cleveland Clinic

This CME activity will provide a comprehensive update on current and emerging applications of stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS). Through expert-led lectures, case discussions, and debates, participants will review advances in clinical practice, technology integration, and research related to brain, spine, functional, and vascular radiosurgery. A broad range of organ-specific technical and clinical experience will be presented with opportunities to interact with faculty and system vendors.

Tél.: [2163859076];     Email.: eatonl3@ccf.org

oncology, neurology, neurosurgery, dosimetry, medical physics, radiation oncology, research, stereotactic radiation therapy, stereotactic radiosurgery

Formation médicale continue (FMC),    Neurologie

The European Association for Cancer Research (EACR)

Join us online on 24 and 25 February 2026 to explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications, with a particular focus on innovative therapeutic strategies. The programme will include invited talks from leading scientists in areas such as novel NK, T and myeloid cell therapies, mRNA therapies, and new combinatorial immune checkpoint blockade strategies. It will provide a broad overview and detailed knowledge of novel targets and new therapeutic strategies in this field. If your work centres on any of the topics mentioned above, you may be able to present it at our conference! Submit an abstract by 12 January 2026 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation! Participant registration closes on 02 February 2026.

Conference Officer: Chris Iliffe;     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer immunotherapy, next-gen approaches to cancer therapies, cancer resistance, overcoming cancer resistance, novel NK cell therapy, novel T-cell therapy, novel myeloid cell therapy, mRNA therapy, cytokine targeting, personalised immunotherapies, basic cancer research, translational cancer research, pre-clinical cancer research, clinical applications

Das 8. Leipziger Hämatologie Symposium (LHS) ist eine zweitägige Präsenzfortbildung in der Kongresshalle am Zoo Leipzig, bei der renommierte Expertinnen und Experten aus ganz Deutschland aktuelle Entwicklungen in der hämatologischen Forschung, Diagnostik und Therapie vorstellen. Im Mittelpunkt stehen praxisrelevante Updates sowie der intensive wissenschaftliche Austausch zwischen Klinik und Praxis.

event lab.;     Tél.: [0341 30 88 84 71];     Email.: bschulte@eventlab.org

Leipziger Hämatologie Symposium, LHS 2026, Hämatologie, Onkologie, Leipzig, KONGRESSHALLE am Zoo, Fortbildung, wissenschaftliches Symposium, Diagnostik, Therapie, Universitätsklinikum Leipzig

ESMO - European Society for Medical Oncology

The ESMO Sarcoma and Rare Cancers Congress 2026 will once again serve as a premier forum for sharing groundbreaking research, novel treatment strategies, and fostering collaborations to drive progress in this crucial area of oncology. Join us from 12–14 March 2026 in the charming city of Lugano, Switzerland, renowned for its stunning lakeside views and rich cultural heritage. The scientific and educational programme will explore the latest advancements in diagnosis, treatment, biology, and molecular classification of rare solid tumours, ensuring a comprehensive update on the evolving landscape of these complex diseases. Attendees can engage in Abstract-related sessions, educational lectures, Multidisciplinary Tumour Boards, Special Sessions, Guidelines discussions, and dedicated Young Oncologists sessions, all designed to enhance knowledge and foster interactive discussions. Whether you are a clinician, researcher, healthcare professional, industry expert, or patient advocate, this congress offers a unique opportunity to connect, learn, and contribute to the future of sarcoma and rare cancer care.

ESMO Meetings Operations Team;     Tél.: [+41 91 97 31 946];     Email.: meetings@esmo.org

Sarcoma biology, Rare cancers, Tumour microenvironment, Molecular diagnostics, Genomic profiling, Precision oncology, Biomarkers of response, Immunotherapy in sarcomas, Targeted therapy, Novel drug development, Clinical trials phase I, Clinical trials phase II, Clinical trials phase III, Multimodal therapy, Resistance mechanisms, Long-term survivorship, Real-world evidence, Surgery, Radiation therapy, Systemic therapy, Chemotherapy, Targeted agents, Immunomodulators, CAR T-cell therapy, Checkpoint inhibitors, Antiangiogenic therapy, Gene therapy, Combination therapies, Soft tissue sarcoma, Bone sarcoma, GIST, Liposarcoma, Leiomyosarcoma, Undifferentiated pleomorphic sarcoma, Ewing sarcoma, Osteosarcoma, Rhabdomyosarcoma, Synovial sarcoma, Rare mesenchymal tumours, Quality of life, Patient-reported outcomes, Survivorship, Toxicity management, Side effects, Late effects, Palliative care, Patient access, Health equity, Cost effectiveness, Health policy, Imaging techniques, MRI, PET-CT, Functional imaging, Liquid biopsy, Bioinformatics, AI, Single-cell sequencing, Molecular subtyping, Pathology standards, Abstract submission, Late breaker, Keynote lecture, Workshops, Poster sessions, Multidisciplinary teams, Collaborative networks, Guidelines, Consensus statements, Regulatory framework

Biologie médicale,    Chirurgie

Keystone Symposia

While immunotherapies have transformed cancer treatment, they only benefit a subset of patients, with many failing to respond or quickly developing resistance. This Keystone Symposia will examine the limitations of immunotherapies, the reasons for failure and mechanisms of resistance, in order to guide strategies to overcome these hurdles and improve clinical outcomes.

European Society for Medical Oncology (ESMO)

The journey of innovation in cancer treatment begins with early drug development. ESMO TAT serves as a dynamic, multi-stakeholder forum, uniting researchers, industry leaders, investors and regulators under one roof to accelerate the delivery of life-changing anticancer therapies to patients. Join us in the pursuit to advance cancer treatment: we look forward to seeing you at this transformative event, to share new data, foster collaboration, and tackle challenges that will drive early clinical development forward.

The European Association for Cancer Research (EACR)

Designing efficient novel therapeutics cannot be achieved without understanding the dynamics of the tumour microenvironment or of reciprocal cancer-stroma interactions and how they are modulated by cancer treatments. With this in mind, the second edition of this conference topic will cover the latest exciting breakthroughs in this field. Specialist themes include the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs, novel insights into tumour-host interactions including the nervous system, and response to therapy. If you’re interested in translational cancer biology, immunology, and therapeutics – whether you’re a scientist, postdoc, graduate student, industry scientist, or journal editor – then this conference is not to be missed. Submit your application by 19 January 2026 for the chance to present your work and register by 16 February 2026 to join us in Bergamo.

Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org

cancer research, oncology, tumour microenvironment, novel therapeutics, cancer cells, stromal cells, cancer-stroma interactions, cancer immunology, tumour-host interactions, treatment response

Keystone Symposia

This Keystone Symposia Conference will explore interactions between tumor cells and their surrounding microenvironment, examining both tumor-intrinsic and -extrinsic signaling programs that influence cancer progression and systemic host responses such as aging, cachexia, obesity, and immunity.

The European Association for Cancer Research (ECAR)

eMedEd

The Cancer Care and Cardiology Conference 2026 is a multidisciplinary CME event bringing together cardiologists, oncologists, and healthcare professionals to discuss advances in cardio-oncology, management of cardiotoxicity, and collaborative approaches to patient care.

Conference Secretariat;     Tél.: [+1-555-123-4567];     Email.: info@emedevents.com

advanced cardiology care, Cancer Care, cardiological care, cardiology care, cardiology cme, Cardiology CME Conferences, cardiology cme courses​, Cardiology Conference, Cardiology Conference 2026, Cardiology Conferences 2026, care oncology, clinical care oncology, CME Cardiology, cme oncology, emedevents, International Oncology Conference, medical oncology conference, Ohio CME, Ohio CME Conference, Oncology Care, oncology cme, oncology conference, oncology conferences usa, oncology nursing conference

The European Association for Cancer Research (EACR)

The 7th edition of this extremely popular conference topic will be held in Essen, Germany on 12-14 May 2026. It will showcase the latest breakthroughs in cancer genomics, multiomics, and computational biology, covering topics including machine learning and artificial intelligence, single-cell and spatial analysis of cancers, cell plasticity, cancer immune genomics, data integration and convergence, epigenetics, and genomic instability. If your work centres on any of these topics, you may be able to present it at our conference! Submit an abstract by 16 March 2026 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation! Participant registration closes on 13 April 2026.

Conference Officer: Chris Iliffe;     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer genomics, cancer multiomics, computational cancer biology, machine learning, artificial intelligence, single-cell analysis, spatial analysis, cancer cell plasticity, cancer immune genomics, data integration and convergence, cancer epigenetics, genomic instability, molecular pathology, cancer evolution, immune evasion, bioinformatics, systems biology, translational cancer research

Biologie des systèmes,    Génomique et bio-informatique

The European Association for Cancer Research (ECAR)

The 2026 Annual Congress of the European Association for Cancer Research (EACR 2026) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Keystone Symposia

The meeting will bring together disparate fields to consider the tumor in the context of the entire organism, broadening the scope and complexity of cancer metabolism research to generate novel insights with clinical impacts. By bringing together scientists and clinicians across siloed fields, we aim to inspire cross-disciplinary collaborations that will yield transformative treatment strategies and accelerate clinical advances.

The Beljanski Foundation

The Beljanski Integrative Cancer Conference (June 26–29, 2026 San Diego, CA) is a 3-day, science-driven event featuring 25+ of the world’s leading integrative cancer experts, where attendees can meet the speakers in person, ask questions directly, and take part in live discussions on evidence-based, plant-compound research, cancer stem cell breakthroughs, and integrative cancer care while supporting ongoing research through The Beljanski Foundation. Learn more at INTEGRATIVECANCERCONFERENCE.COM.

Tél.: [6468085583];     Email.: raphaela@maisonbeljanski.com

Integrative Cancer, experts, conference, plant compound

The 5th SCPSC will feature an innovative program reflecting the evolving fields of palliative oncology and psycho-oncology, uniting leading researchers from around the world. Palliative care is entering a new era of research and clinical practice.

Fusion

Felicity Harrap, Conference Manager;     Email.: felicity@fusion-conferences.com

Cancer immunology, Immunotherapy, Tumour Immunology Integrated multi-omics, Tissue niches, Metabolism, Cancer, Lymphatic Vessels, Cutaneous Immunity, Melanoma, T cell Trafficking, Lymph Nodes, Antigens, Differentiation, T-Lymphocyte, Carcinoma, Non-Small-Cell Lung, Genes, Tumor Suppressor; Oncogenes, Cytotoxic, Helper-Inducer, Regulatory, Tumor Microenvironment

Stem Network

Our Cancer and Oncology conference unites specialists to deliver seminal research, novel methodologies, and the most recent findings in cancer and oncology. Network with industry pioneers, delve into latest developments, and learn pertinent insights defining the future of the discipline.

+41 77 414 46 91;     Tél.: [+1 (872) 2138-777];     Email.: cancer.cgs@stemnetwork.net

Cancer Biology and Genetics, Cancer Diagnosis and Early Detection, Precision Medicine in Oncology, Immuno-Oncology and Cancer Immunotherapy, Targeted Therapies and Clinical Trials, Radiation and Surgical Oncology, Pediatric and Rare Cancers, Cancer Prevention and Public Health

Stem Network

CGS 2026 covers a wide range of topics in oncology and cancer therapeutics, including tumor biology, immuno-oncology, genomics, early detection, precision medicine, novel drug delivery, AI in oncology, and more. Sessions are designed to inspire collaboration, spark innovation, and highlight breakthroughs in both research and clinical practice.

+41 77 414 46 91;     Tél.: [+1 (872) 2138-777];     Email.: oncology.cgs@stemnetwork.net

1. Tumor Biology and Microenvironment 2. Cancer Genomics and Molecular Pathways 3. Immuno-Oncology and Precision Therapies 4. Early Detection, Screening, and Biomarker Development 5. Metastasis and Resistance Mechanisms 6. AI and Digital Health in Oncology 7. Pediatric and Rare Cancers 8. Cancer Prevention and Lifestyle Factors 9. Novel Drug Delivery Systems and Nanotechnology 10. Translational and Clinical Research

The European Association for Cancer Research (EACR)

The 5th edition of this topic builds on the success of our largest topic-focussed meeting yet, which brought 340 cancer researchers together to learn and network. This time, our expert panel of speakers will guide participants through undocumented metabolic alterations, complex tumour-host interactions, and the mechanisms metabolites use to regulate cell decisions. The ultimate aim of this conference is to expand the horizons for vulnerabilities that can be exploited in cancer treatment.

Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, cancer metabolism, undocumented metabolic alterations, metabolic reprogramming, tumour-host interactions, tumour niches, cancer cells, stromal cells, metabolic regulation, cell fate decisions, metabolic mechanisms in cancer, metabolic vulnerabilities in cancer, cancer metastasis, cancer progression

Biologie,    Biologie moléculaire

Keystone Symposia

This meeting will present work that encompasses the influence of hormones on driving cancer across the lifespan, through influences on aging, immunity, and other factors. Many current studies in aging and cancer do not adequately consider the impact of hormones, hormone receptors, and changing hormone levels as drivers of these processes. This meeting will assemble researchers across the fields of endocrinology, aging, and oncology to discuss the interplay of these multiple factors and how they should be considered when diagnosing and treating cancers. The meeting will span basic, translational, and clinical research to drive bench to bedside and bedside and back insights that will advance our understanding of cancer etiology, prevention, and treatment approaches. The meeting will bridge interdisciplinary groups of scientists, population scientists, and clinicians, allowing a unique blend of discovery in the hormones over the lifespan, aging, immunity, and cancer.

Cancer, Hormones, Endocrinology, Oncology, Aging, Immunology, Bench to Bedside, Clinical Research, Translational Research

Biologie,    Immunologie et Allergie

The European Association for Cancer Research (ECAR)

The EACR Conference on Chromosomes in Crisis: From Chromosomal Instability to Catastrophes in Cancer Genomes will bring together leading experts to explore the mechanisms, consequences, and therapeutic vulnerabilities associated with these genomic rearrangements. Join us in Berlin, Germany, to uncover how chromosomal chaos shapes cancer biology and opens new avenues for clinical intervention.

Mathews International llc

ICPOC 2026 promotes interdisciplinary knowledge exchange and collaboration, enabling participants to share research findings and explore emerging oncology trends. The Precision Oncology Conference also supports professional networking across global healthcare and research communities.

conference manager;     Tél.: [+1 (312) 462 4448];     Email.: cancer@mathewsconference.com

Genomic Instability and Mutations, Epigenetics and Gene Regulation, Metabolism and Cancer, Mechanisms of Metastasis

European Association for the Study of the Liver (EASL)

Liver tumours

Keystone Symposia

Cancer Immunotherapy: Bridging Basic Research and Clinical Translation brings together immunologists, oncologists, bioengineers, and translational scientists to accelerate the next generation of cancer therapies. The meeting spotlights immune-based approaches spanning foundational discovery to clinical application, highlighting how insights from basic biology are reshaping cancer treatment. Program sessions showcase advances in checkpoint therapies, cellular and engineered immunotherapies, cancer vaccines, and tumor microenvironment, and emphasize how innate and adaptive immune responses can be harnessed and optimized to improve therapeutic outcomes.

Cancer, Immunotherapy, Oncology, Biomedical Engineering, Bioengineering, Therapeutics, Translational Research, Protein Engineering

Biologie moléculaire,    Biotechnologie